{"altmetric_id":2299470,"counts":{"readers":{"mendeley":44,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["224650121076716"],"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[399],"posts_count":1},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["amango30","RevistaMFSamfyc"],"posts_count":2}},"selected_quotes":["Inhibici\u00f3n del cotransportador sodio-glucosa 2 y control gluc\u00e9mico en la diabetes tipo 1 Diabetes Care"],"citation":{"abstract":"Adjunctive-to-insulin therapy with sodium-glucose cotransporter 2 (SGLT2) inhibition may improve glycemic control in type 1 diabetes (T1D).","abstract_source":"pubmed","altmetric_jid":"4f6fa4eb3cf058f6100026f8","authors":["Bruce A. Perkins","David Z.I. Cherney","Helen Partridge","Nima Soleymanlou","Holly Tschirhart","Bernard Zinman","Nora M. Fagan","Stefan Kaspers","Hans-Juergen Woerle","Uli C. Broedl","Odd-Erik Johansen"],"doi":"10.2337\/dc13-2338","first_seen_on":"2014-04-23T16:31:52+00:00","issns":["1935-5548"],"journal":"Diabetes Care","last_mentioned_on":1411642637,"links":["http:\/\/care.diabetesjournals.org\/content\/early\/2014\/02\/27\/dc13-2338.abstract?sid=4ea36efd-ad79-45e8-a7e6-a664da16f841","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24595630","http:\/\/care.diabetesjournals.org\/content\/37\/5\/1480.full.pdf","http:\/\/care.diabetesjournals.org\/content\/37\/5\/1480.full.pdf+html"],"pdf_url":"http:\/\/care.diabetesjournals.org\/content\/early\/2014\/02\/27\/dc13-2338.full.pdf","pmid":"24595630","pubdate":"2014-03-04T00:00:00+00:00","publisher":"American Diabetes Association Inc.","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences","Nursing"],"subjects":["endocrinology"],"title":"Sodium-Glucose Cotransporter 2 Inhibition and Glycemic Control in Type 1 Diabetes: Results of an 8-Week Open-Label Proof-of-Concept Trial","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/sodiumglucose-cotransporter-2-inhibition-glycemic-control-type-1-diabetes-results-8week-openlabel-pr"},"altmetric_score":{"score":8.502,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.502},"context_for_score":{"all":{"total_number_of_other_articles":6580471,"mean":6.104698587791,"rank":754259,"this_scored_higher_than_pct":88,"this_scored_higher_than":5826309,"rank_type":"exact","sample_size":6580471,"percentile":88},"similar_age_3m":{"total_number_of_other_articles":149006,"mean":7.7387037616189,"rank":21600,"this_scored_higher_than_pct":85,"this_scored_higher_than":127406,"rank_type":"exact","sample_size":149006,"percentile":85},"this_journal":{"total_number_of_other_articles":4683,"mean":12.931251174712,"rank":1351,"this_scored_higher_than_pct":71,"this_scored_higher_than":3333,"rank_type":"exact","sample_size":4683,"percentile":71},"similar_age_this_journal_3m":{"total_number_of_other_articles":82,"mean":22.954592592593,"rank":38,"this_scored_higher_than_pct":53,"this_scored_higher_than":44,"rank_type":"exact","sample_size":82,"percentile":53}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Professor > Associate Professor":4,"Librarian":1,"Researcher":10,"Student  > Ph. D. Student":6,"Student  > Postgraduate":5,"Other":7,"Student  > Master":5,"Student  > Bachelor":6},"by_discipline":{"Medicine and Dentistry":33,"Agricultural and Biological Sciences":4,"Nursing and Health Professions":2,"Biochemistry, Genetics and Molecular Biology":3,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"ES":1},"mendeley":{"KR":1,"JP":1,"BR":1,"MX":1,"GB":1}}},"posts":{"blogs":[{"title":"T2 Diabetes &ldquo;Pee Drug&rdquo; Useful for Type 1 Too?","url":"http:\/\/www.diabetesmine.com\/2014\/04\/t2-diabetes-pee-drug-for-type-1.html","citation_ids":[818858,2299470],"posted_on":"2014-04-23T11:00:00+00:00","summary":"A little pee could go a long way in helping type 1s get their blood sugars in line.\nAt least that&rsquo;s what researchers think about the new class of drugs known as SGLT-2 inhibitors, which are designed for use in&hellip;The post T2 Diabetes &ldquo;Pee D","author":{"name":"DiabetesMine: the all things diabetes blog","url":"http:\/\/www.diabetesmine.com\/","description":"A gold mine of straight talk and encouragement for people living with diabetes"}}],"twitter":[{"url":"https:\/\/twitter.com\/amango30\/status\/515092671229329408","license":"datasift","rt":["RevistaMFSamfyc"],"citation_ids":[2299470],"posted_on":"2014-09-25T10:57:17+00:00","author":{"name":"Antonio Manteca","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000095310075\/e3761435f8f78dcd6c84ed7f7c2c8ac3_normal.jpeg","id_on_source":"amango30","tweeter_id":"332317568","geo":{"lt":36.77262,"ln":-4.10045,"country":"ES"},"followers":101},"tweet_id":"515092671229329408"},{"url":"https:\/\/twitter.com\/RevistaMFSamfyc\/status\/515085937584652288","license":"datasift","citation_ids":[2299470],"posted_on":"2014-09-25T10:30:32+00:00","author":{"name":"Revista MFAndalucia","image":"https:\/\/pbs.twimg.com\/profile_images\/2159845648\/logo_BUENO_RevistaRGB_normal.jpg","id_on_source":"RevistaMFSamfyc","tweeter_id":"559316806","geo":{"lt":null,"ln":null},"followers":499},"tweet_id":"515085937584652288"}],"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=253078624900532&id=224650121076716","license":"public","citation_ids":[2299470],"posted_on":"2014-07-13T23:59:16+00:00","summary":"Perspectiva interessante: uso de inibidor do SGLT2 no diabetes mellitus tipo 1, como adjuvante \u00e0 insulina...\ndispon\u00edvel em open access no link:\nhttp:\/\/care.diabetesjournals.org\/content\/37\/5\/1480.full.pdf+html","author":{"name":"Exercite SA\u00daDE","url":"https:\/\/www.facebook.com\/224650121076716","facebook_wall_name":"Exercite SA\u00daDE","image":"https:\/\/graph.facebook.com\/224650121076716\/picture","id_on_source":"224650121076716"}}]}}